Review: the physiological and computational approaches for atherosclerosis treatment

Wuchen Wang1, Yugyung Lee, Chi H Lee

  • 1Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri, Kansas City, MO 64108, USA.

Insights

Cardiovascular disease, driven by atherosclerosis, leads to arterial malfunction and thrombosis. This review covers the progression from plaque to clot formation and mitigation strategies like percutaneous coronary intervention.

Area of Science:

  • Cardiovascular Science
  • Biomedical Engineering

Background:

  • Cardiovascular diseases represent a significant global health burden, particularly conditions linked to arterial malfunction.
  • Atherosclerosis, characterized by plaque buildup in arteries, is a primary driver of these conditions.
  • The progression from atherosclerotic plaque to arterial thrombosis poses a severe clinical challenge.

Purpose of the Study:

  • To review the physiological mechanisms linking atherosclerosis to platelet aggregation and thrombosis.
  • To discuss current physiological and computational approaches for managing this pathological progression.
  • To highlight the role of interventions like percutaneous coronary intervention and stent design.

Main Methods:

  • Literature review of physiological mechanisms of thrombosis.
  • Analysis of computational modeling techniques in cardiovascular interventions.
  • Examination of percutaneous coronary intervention and stent design in mitigating thrombotic events.

Main Results:

  • Detailed explanation of the transition from atherosclerotic plaque formation to platelet aggregation and thrombus development.
  • Overview of diagnostic and therapeutic strategies targeting the atherosclerotic-thrombotic cascade.
  • Discussion on the application of computational modeling for optimizing stent design and intervention outcomes.

Conclusions:

  • Understanding the physiological cascade from atherosclerosis to thrombosis is crucial for developing effective treatments.
  • Physiological and computational approaches offer promising avenues for detecting, evaluating, and mitigating thrombotic progression.
  • Interventional strategies, including percutaneous coronary intervention and advanced stent design, play a vital role in managing cardiovascular disease progression.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...